- Report
- December 2023
- 110 Pages
Global
From €4178EUR$4,650USD£3,643GBP
- Report
- January 2024
- 69 Pages
Asia Pacific
From €2650EUR$2,950USD£2,311GBP
- Report
- July 2023
- 166 Pages
Global
From €2471EUR$2,750USD£2,155GBP
€4942EUR$5,500USD£4,309GBP
- Report
- February 2026
- 200 Pages
Saudi Arabia
From €2686EUR$2,990USD£2,343GBP
- Report
- May 2025
- 200 Pages
Italy
From €2237EUR$2,490USD£1,951GBP
- Report
- July 2023
- 210 Pages
Global
From €1788EUR$1,990USD£1,559GBP
- Report
- December 2023
- 82 Pages
Europe
From €1325EUR$1,475USD£1,156GBP
€2650EUR$2,950USD£2,311GBP
- Report
- January 2025
- 139 Pages
Global
From €3593EUR$3,999USD£3,133GBP
- Report
- February 2025
- 329 Pages
Global
From €4043EUR$4,500USD£3,526GBP
- Report
- March 2024
- 125 Pages
Global
From €5346EUR$5,950USD£4,662GBP
- Report
- November 2023
- 181 Pages
Global
From €4043EUR$4,500USD£3,526GBP
- Report
- January 2025
- 84 Pages
Vietnam
From €3145EUR$3,500USD£2,742GBP
- Report
- December 2024
- 88 Pages
India
From €3145EUR$3,500USD£2,742GBP
- Report
- December 2024
- 82 Pages
India
From €3145EUR$3,500USD£2,742GBP
- Report
- July 2024
- 82 Pages
India
From €3145EUR$3,500USD£2,742GBP
- Report
- May 2024
- 296 Pages
Global
From €4492EUR$5,000USD£3,918GBP
- Report
- August 2023
- 145 Pages
Global
From €2830EUR$3,150USD£2,468GBP
- Report
- February 2024
- 113 Pages
Global
From €4268EUR$4,750USD£3,722GBP
- Report
- April 2023
- 120 Pages
Global
From €4268EUR$4,750USD£3,722GBP
- Report
- February 2024
- 78 Pages
India
From €4268EUR$4,750USD£3,722GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more